Guipavas, France

Alicia Quillevere


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alicia Quillevere: Innovator in Cancer Treatment

Introduction

Alicia Quillevere, an accomplished inventor based in Guipavas, France, has made significant contributions to the field of biomedical sciences. Her primary focus is on developing innovative treatments for cancers associated with the Epstein-Barr Virus (EBV). With a strong academic and professional background, Quillevere stands out as a trailblazer in her domain.

Latest Patents

Alicia Quillevere holds a notable patent titled "Hydrazone derivatives for preventing or treating EBV-related cancers." This invention relates to novel bis-hydrazone derivatives with specific chemical formulas that demonstrate potential as drugs. The compositions and kits comprising these derivatives are specifically designed for the treatment and prevention of cancers associated with EBV, showcasing Quillevere's dedication to combating serious health issues through innovation.

Career Highlights

Throughout her career, Alicia Quillevere has collaborated with prestigious institutions that have furthered her research endeavors. Notably, she has been associated with the Université de Bretagne Occidentale and the Centre Hospitalier Régional Universitaire de Brest. Her work in these organizations has facilitated advancements in her research, enabling her to focus on critical areas of cancer treatment.

Collaborations

In her professional journey, Quillevere has worked alongside esteemed colleagues, including Marc Blondel and Cécile Voisset. These collaborations have fostered an environment of innovation and have helped propel her research to new heights. The synergy between these professionals has significantly contributed to their collective achievements in the scientific community.

Conclusion

Alicia Quillevere's innovative spirit and commitment to addressing serious health challenges through her patent work are commendable. As she continues to explore new avenues in cancer treatment, her contributions will undoubtedly have a lasting impact on the field of biomedical research. Her dedication inspires future inventors to innovate and seek solutions for some of the world's most pressing medical needs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…